Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.

Abstract

UNLABELLED:

Plasma cell neoplasm (PCM) is a medullary and extra medullary proliferation of clonal plasma cells that occurs due to accidental translocation of proto-oncogenes into immunoglobulin (Ig) gene loci. While the majority of plasma cell neoplasms are monoclonal, up to 2% of the PCMs [1] considered being biclonal based on electrophoretic analysis, characterized by secretion of paraprotein with two distinct heavy chains or light chains are possible and present unique diagnostic challenges.

METHODS:

Traditionally protein electrophoresis has been used to diagnose, characterize, and monitor progression of plasma cell neoplasm. To characterize neoplastic plasma cells, in our institution, other ancillary studies, including in situ hybridization, flow cytometric analyses of plasma cell surface markers and cytoplasmic immunoglobulins with DNA ploidy, are also utilized routinely.

RESULTS:

We present two cases of plasma cell myeloma in which the neoplastic plasma cells shows production of cytoplasmic kappa and lambda light chain, with secretion of free lambda light chain only. Co-expression of kappa and lambda light chain by the same neoplastic plasma cells is a rare but reported phenomenon.

CONCLUSIONS:

Our study indicates that serum electrophoresis alone could mischaracterize biphenotypic myeloma as monotypic plasma cell myelomas in the absence of additional testing methods.

• Authors: Shahanawaz Jiwani, Joshua Bornhost, Daisy Alapat
• Journal: International journal of clinical and experimental pathology (Int J Clin Exp Pathol) Vol. 8 Issue 7 Pg. 8536-44 ( 2015) ISSN: 1936-2625 [Electronic] United States
• PMID: 26339430 (Publication Type: Case Reports, Journal Article)

Chemical References

• Biomarkers, Tumor
• Immunoglobulin kappa-Chains
• Immunoglobulin lambda-Chains
• RNA, Messenger

Topics

• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Biomarkers, Tumor (analysis, blood, genetics)
• Electrophoresis, Capillary
• Fatal Outcome
• Female
• Flow Cytometry
• Humans
• Immunoglobulin kappa-Chains (analysis, blood, genetics)
• Immunoglobulin lambda-Chains (analysis, blood, genetics)
• Immunohistochemistry
• Immunophenotyping (methods)
• In Situ Hybridization
• Male
• Middle Aged
• Multiple Myeloma (blood, diagnosis, drug therapy, genetics, immunology)
• Phenotype
• Predictive Value of Tests
• RNA, Messenger (genetics)
• Treatment Outcome